BioCatalyst

AZD0780 — catalyst calendar

2 verified catalyst event(s) referencing AZD0780, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-04
in 2mo
ESTIMATED
 READOUT
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
Phase 3 · Heterozygous Familial Hypercholesterolaemia
 AZN ASTRAZENECA PLC AZD0780 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-01-11
in 2mo
ESTIMATED
 READOUT
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clin
Phase 3 · Cardiovascular Disease
 AZN ASTRAZENECA PLC AZD0780 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.